[1] World Health Organization. Global Hepatitis Report: 2017[R]. France: WHO, 2017.
[2] 袁怡. 靶向HBV核心蛋白二聚体形成的药物筛选及鉴定[D]. 重庆: 重庆医科大学, 2020: 45-52.
[3] Zlotnick A, Venkatakrishnan B, Tan Z, et al. Core protein: A pleiotropic keystone in the HBV lifecycle[J]. Antiviral Research, 2015, 121(1): 82-93.
[4] Seeger C, Mason W S. Molecular biology of hepatitis B virus infection[J]. Virology, 2015, 479/480: 672-86.
[5] Xia Y, Liang T J. Development of directacting antiviral and hosttargeting agents for treatment of hepatitis b virus infection[J]. Gastroenterology, 2019, 156(2): 311-324.
[6] Ludgate L, Liu K, Luckenbaugh L, et al. Cellfree hepatitis b virus capsid assembly dependent on the core protein cterminal domain and regulated by phosphorylation[J]. Journal of Virology, 2016, 90(12): 5830-5844.
[7] Chain B M, Myers R. Variability and conservation in hepatitis B virus core protein[J]. BMC Microbiology, 2005, 5(1): 33-40.
[8] Ponsel D, Bruss V. Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation[J]. Journal of Virology, 2003, 77(1): 416-22.
[9] Rost M, Mann S, Lambert C, et al. Gammaadaptin, a novel ubiquitininteracting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation[J]. Journal of Biological Chemistry, 2006, 281(39): 29297-29308.
[10] Langerová H, Lubyová B, Zábransk A, et al. Hepatitis b core protein is posttranslationally modified through K29linked ubiquitination[J]. Cells, 2020, 9(12): 2547-2550.
[1]陈周伟,朱丽敏,朱聪,等.乙肝病毒编码miRNA的预测及鉴定[J].浙江理工大学学报,2015,33-34(自科2):253.
CHEN Zhou wei,ZHU Li min,ZHU Cong,et al.Prediction and Identification of HBVEncoded miRNA[J].Journal of Zhejiang Sci-Tech University,2015,33-34(自科一):253.